ICYMI: A New Year, a New Autoinflammatory Disease, and a Promising New Drug
source: pixabay.com

ICYMI: A New Year, a New Autoinflammatory Disease, and a Promising New Drug

  According to a recent article in Pharma Tutor, researchers at NHGRI, a division of the National Institute of Health, identified the biological cause of a newly-discovered autoinflammatory disease they named…

Continue Reading ICYMI: A New Year, a New Autoinflammatory Disease, and a Promising New Drug
A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
source: pixabay.com

A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials

According to a story from Acrofan, the biotechnology company Clover Pharmaceuticals Inc. has recently announced that the first patient has been dosed in its phase 3 clinical study. This study…

Continue Reading A Biosimilar Drug for Treating Rheumatoid Arthritis and Ankylosing Spondylitis Begins Phase 3 Trials
A Polycystic Kidney Disease Patient’s Advertisement for a Kidney Donor Finds a Surprising Match
source: pixabay.com

A Polycystic Kidney Disease Patient’s Advertisement for a Kidney Donor Finds a Surprising Match

  By Rachel Whetstone from In The Cloud Copy Shelly Wheaton began a car sign campaign in September to look for a live kidney donor. She was on dialysis because…

Continue Reading A Polycystic Kidney Disease Patient’s Advertisement for a Kidney Donor Finds a Surprising Match